Irbaz Bin Riaz

5.6k total citations · 1 hit paper
213 papers, 3.4k citations indexed

About

Irbaz Bin Riaz is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Irbaz Bin Riaz has authored 213 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Pulmonary and Respiratory Medicine, 69 papers in Oncology and 47 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Irbaz Bin Riaz's work include Prostate Cancer Treatment and Research (37 papers), Cancer Treatment and Pharmacology (20 papers) and Radiopharmaceutical Chemistry and Applications (19 papers). Irbaz Bin Riaz is often cited by papers focused on Prostate Cancer Treatment and Research (37 papers), Cancer Treatment and Pharmacology (20 papers) and Radiopharmaceutical Chemistry and Applications (19 papers). Irbaz Bin Riaz collaborates with scholars based in United States, Pakistan and United Kingdom. Irbaz Bin Riaz's co-authors include M. Hassan Murad, Jawad Bilal, Faiz Anwer, Haris Riaz, Abbas Rana, Rainer W.G. Gruessner, Angelika C. Gruessner, Muhammad Shahzeb Khan, Bruce Kaplan and Muhammad Husnain and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Irbaz Bin Riaz

185 papers receiving 3.4k citations

Hit Papers

Survival Benefit of Solid-Organ Transplant in the United ... 2015 2026 2018 2022 2015 100 200 300

Peers

Irbaz Bin Riaz
James A. Kaye United States
Sercan Aksoy Türkiye
Christina Fotopoulou United Kingdom
Lesley Anderson United Kingdom
Irbaz Bin Riaz
Citations per year, relative to Irbaz Bin Riaz Irbaz Bin Riaz (= 1×) peers María A. López-Olivo

Countries citing papers authored by Irbaz Bin Riaz

Since Specialization
Citations

This map shows the geographic impact of Irbaz Bin Riaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irbaz Bin Riaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irbaz Bin Riaz more than expected).

Fields of papers citing papers by Irbaz Bin Riaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irbaz Bin Riaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irbaz Bin Riaz. The network helps show where Irbaz Bin Riaz may publish in the future.

Co-authorship network of co-authors of Irbaz Bin Riaz

This figure shows the co-authorship network connecting the top 25 collaborators of Irbaz Bin Riaz. A scholar is included among the top collaborators of Irbaz Bin Riaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irbaz Bin Riaz. Irbaz Bin Riaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghaffar, Umar, Amara Tariq, Logan Briggs, et al.. (2025). DOMAIN-SPECIFIC LARGE LANGUAGE MODEL FOR PREDICTING PROSTATE CANCER TREATMENT PLAN. Urologic Oncology Seminars and Original Investigations. 43(3). 41–41.
2.
Naqvi, Syed Arsalan Ahmed, Zhaohui Jin, Harry H. Yoon, et al.. (2025). Efficacy of perioperative and neoadjuvant therapies in gastric and gastroesophageal junction adenocarcinoma: a network meta-analysis. The Oncologist. 30(8). 2 indexed citations
4.
Zarka, Jonathan, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, et al.. (2025). 2403P LuRa: Efficacy and Tolerability of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer. Annals of Oncology. 36. S1223–S1223.
5.
Swami, Umang, Yeonjung Jo, Nicolas Sayegh, et al.. (2025). Real-world use of bone-modifying agents (BMA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the US.. Journal of Clinical Oncology. 43(5_suppl). 95–95.
6.
Naqvi, Syed Arsalan Ahmed, Jack R. Andrews, Alan H. Bryce, et al.. (2025). Automated risk stratification in localized prostate cancer using an AI-assisted framework.. Journal of Clinical Oncology. 43(5_suppl). 341–341.
7.
Ahmed, Mohamed E., Ahmed Mahmoud, Irbaz Bin Riaz, et al.. (2024). Survival Patterns Based on First-site–specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same?. European Urology Open Science. 66. 38–45. 3 indexed citations
8.
Riaz, Irbaz Bin, Muhammad Ali Khan, & Tufia C. Haddad. (2024). Potential application of artificial intelligence in cancer therapy. Current Opinion in Oncology. 36(5). 437–448. 9 indexed citations
9.
Mahmoud, Ahmed, Mohamed E. Ahmed, Spyridon P. Basourakos, et al.. (2024). Prostate Cancer Lung Metastasis: Clinical Insights and Therapeutic Strategies. Cancers. 16(11). 2080–2080. 2 indexed citations
10.
Murad, M. Hassan, Zhen Wang, Haitao Chu, et al.. (2023). Proposed triggers for retiring a living systematic review. BMJ evidence-based medicine. 28(5). 348–352. 10 indexed citations
11.
Riaz, Irbaz Bin, Harry E Fuentes, Yihong Deng, et al.. (2023). Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis. JAMA Network Open. 6(7). e2325283–e2325283. 21 indexed citations
12.
Mahmoud, Ahmed, Mohamed E. Ahmed, A. Tuba Kendi, et al.. (2023). Low PSA radiographic disease progression on C11‐choline PET. SHILAP Revista de lepidopterología. 5(2). 319–324. 1 indexed citations
13.
Hussain, Syed A., J.F. Lester, Richard A. Jackson, et al.. (2022). Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 20 indexed citations
14.
Wang, Liwei, Sunyang Fu, Andrew Wen, et al.. (2022). Assessment of Electronic Health Record for Cancer Research and Patient Care Through a Scoping Review of Cancer Natural Language Processing. JCO Clinical Cancer Informatics. 6(6). e2200006–e2200006. 24 indexed citations
15.
Khan, Safi U., Siva H. Yedlapati, Ahmad Naeem Lone, et al.. (2022). PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis. BMJ. 377. e069116–e069116. 65 indexed citations
16.
Sonbol, Mohamad Bassam, Rabbia Siddiqi, Pedro Luiz Serrano Usón, et al.. (2022). The Role of Systemic Therapy in Resectable Colorectal Liver Metastases: Systematic Review and Network Meta-Analysis. The Oncologist. 27(12). 1034–1040. 10 indexed citations
17.
Chakraborty, Rajshekhar, Irbaz Bin Riaz, Saad Ullah Malik, et al.. (2020). Venous thromboembolism risk with contemporary lenalidomide‐based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta‐analysis. Cancer. 126(8). 1640–1650. 31 indexed citations
18.
Riaz, Irbaz Bin, et al.. (2018). Immune-Mediated Hematologic Complications of Checkpoint Inhibitors: A Review of the Literature. Blood. 132(Supplement 1). 5883–5883. 1 indexed citations
19.
Parvaneh, Saman, Bijan Najafi, Nima Toosizadeh, Irbaz Bin Riaz, & Jane Mohler. (2016). Prevalence of Ventricular Ectopy in Older Adults across Different Frailty Levels. Computing in cardiology. 1 indexed citations
20.
Parvaneh, Saman, Bijan Najafi, Nima Toosizadeh, Irbaz Bin Riaz, & Jane Mohler. (2016). Is There Any Association Between Ventricular Ectopy and Falls in Community:dwelling Older Adults?. Computing in cardiology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026